RxDoctor Payments Data

Ashleigh Warren

Family · Conover, NCNPI 1265022776

Payments from drug & device makers

$598in general payments, 2019–2025

Across 35 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$115
  • Novartis$86
  • Merck$54
  • Johnson & Johnson$50
  • Cvrx, Inc.$49
  • Amgen$46
  • plus $199 from 7 others

What the payments were for

  • Food & beverage$598100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$598 in reported general payments places this provider in the 60th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$34,948
Medicare patients
185
Services billed
554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban467$372,235
Repatha SyringeEvolocumab36$33,173
BrilintaTicagrelor70$32,946
XareltoRivaroxaban31$29,172
EntrestoSacubitril/Valsartan21$28,577
JardianceEmpagliflozin22$25,019
Repatha SureclickEvolocumab16$13,844
Metoprolol Succinate275$3,154
Ranolazine ErRanolazine24$2,873
Rosuvastatin Calcium112$1,799
Diltiazem 24hr Er (Cd)Diltiazem Hcl68$1,478
Metoprolol Tartrate185$897
Losartan Potassium142$895
Carvedilol129$812
Atorvastatin Calcium90$791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$115$372,235467 claims
Johnson & JohnsonXarelto$50$29,17231 claims
NovartisEntresto$86$28,57721 claims
Boehringer IngelheimJardiance$13$25,01922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,522 family providers in North Carolina.

Other family in Conover

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →